Similar articles

• Parkinson's disease.

  Clarke C, Moore AP. Clarke C, et al. Clin Evid. 2002 Jun;(7):1208-20. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1370-85. PMID: 12230738 Updated. Review. No abstract available.
• Drugs for Parkinson's disease.

  [No authors listed] [No authors listed] Treat Guidel Med Lett. 2011 Jan;9(101):1-6; quiz 2 p following 6. Treat Guidel Med Lett. 2011. PMID: 21304446 Review. No abstract available.
• Parkinson's disease.

  Clarke C, Moore A. Clarke C, et al. Clin Evid. 2002 Dec;(8):1370-85. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):1582-98. PMID: 12603943 Updated. Review. No abstract available.
• [Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].

  Pagonabarraga J, Rodríguez-Oroz MC. Pagonabarraga J, et al. Rev Neurol. 2013 Jan 1;56(1):25-34. Rev Neurol. 2013. PMID: 23250679 Review. Spanish.
• [Drug therapy of Parkinson's disease].

  Myllylä V. Myllylä V. Duodecim. 1997;113(18):1827-34. Duodecim. 1997. PMID: 10892076 Review. Finnish. No abstract available.